Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
6
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Polyrizon Ltd. market cap is $22.08M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Polyrizon Ltd. 52 week high is $18.20 as of November 21, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Polyrizon Ltd. 52 week low is $2.88 as of November 21, 2026.
Polyrizon Ltd. stock price today is $9.31.
Polyrizon Ltd. stock price yesterday was $10.17.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Polyrizon Ltd.'s P/E ratio is -3.38.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Polyrizon Ltd. P/B ratio is 0.8106.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Polyrizon Ltd. 50-day moving average is $10.23.